[Role of enzymatic cross-links and non-enzymatic cross-link, advanced glycation end products, as a determinant of bone quality in osteoporosis and diabetes].
Saito
Mitsuru
M
Department of Orthopaedic Surgery, Jikei University School of Medicine.
D001842:Bone and Bones / Q000378:metabolism* / Q000503:physiopathology; D003094:Collagen / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000378:metabolism* / Q000503:physiopathology; D005265:Femoral Neck Fractures / Q000209:etiology / Q000378:metabolism; D017127:Glycation End Products, Advanced / Q000378:metabolism*; D006710:Homocysteine / Q000378:metabolism; D006801:Humans; D010024:Osteoporosis / Q000378:metabolism* / Q000503:physiopathology; D018384:Oxidative Stress / Q000502:physiology; D013718:Tensile Strength; D026681:Vitamin B 6 Deficiency / Q000150:complications; D014808:Vitamin D Deficiency / Q000150:complications
D017127:Glycation End Products, Advanced; D006710:Homocysteine; D003094:Collagen